Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents are scarce. We report preliminary results of an Italian multicentre study comprising 168 laboratory-confirmed paediatric cases (median: 2.3 years, range: 1 day-17.7 years, 55.9% males), of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, five had seizures, 49 received experimental treatments and all recovered.

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020

Garazzino S.;Rabbone I.;Denina M.;Tovo P. -A.;Pruccoli G.;Ramenghi U.;
2020-01-01

Abstract

Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents are scarce. We report preliminary results of an Italian multicentre study comprising 168 laboratory-confirmed paediatric cases (median: 2.3 years, range: 1 day-17.7 years, 55.9% males), of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, five had seizures, 49 received experimental treatments and all recovered.
2020
25
18
1
4
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.18.2000600
SARS-CoV-2 infection; children; covid-19; hydroxychloroquine; pneumonia; Adolescent; Antiviral Agents; Betacoronavirus; COVID-19; COVID-19 Testing; Child; Child, Preschool; Chronic Disease; Clinical Laboratory Techniques; Coinfection; Comorbidity; Coronavirus; Coronavirus Infections; Diarrhea; Disease Outbreaks; Feces; Female; Fever; Hospitals, Pediatric; Humans; Immunocompromised Host; Infant; Infant, Newborn; Italy; Male; Noninvasive Ventilation; Pandemics; Pneumonia, Viral; Protease Inhibitors; Retrospective Studies; SARS-CoV-2; Severe Acute Respiratory Syndrome; Treatment Outcome
Garazzino S.; Montagnani C.; Dona D.; Meini A.; Felici E.; Vergine G.; Bernardi S.; Giacchero R.; Vecchio A.L.; Marchisio P.; Nicolini G.; Pierantoni L.; Rabbone I.; Banderali G.; Denina M.; Venturini E.; Krzysztofiak A.; Badolato R.; Bianchini S.; Galli L.; Villani A.; Castelli-Gattinara G.; Salvini F.; Abbagnato L.; Castagnola E.; Dodi I.; Ghitti C.; Lippi P.; Agostiniani R.; Cherubini S.; Valentini P.; Gianino P.; Vaccaro A.; Manzoni P.; Verna P.; Comberiati P.; Di Filippo P.; Gallia P.; Battezzati G.; Fiore L.; Dalmazzo C.; Tappi E.; Lazzerini M.; Tovo P.-A.; Scolfaro C.; Pruccoli G.; Ramenghi U.; Giaquinto C.; da Dalt L.; Tornese G.; Berlese P.; Plebani A.; Manno E.C.; Santilli V.; Lancella L.; Cursi L.; Campana A.; Bozzola E.; Bosis S.; Lanari M.; Pecoraro C.; Del Barba P.; Nicastro E.; Esposito S.; Zuccotti G.V.; Corsello G.; Cardinale F.; Tocco A.M.; Ballardini G.; Agostoni C.; Chiappini E.; Indolfi G.; Anna B.; Cazzato S.; Zavarise G.; Pignata C.; Marchetti F.
File in questo prodotto:
File Dimensione Formato  
Garazzinoeurosurv2020.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 112.87 kB
Formato Adobe PDF
112.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1846169
Citazioni
  • ???jsp.display-item.citation.pmc??? 145
  • Scopus 191
  • ???jsp.display-item.citation.isi??? 195
social impact